Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bard v. Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

Bard receives $13.3 mil. in damages following court-of-appeals decision on patent infringement concerning company's Elimination dilation catheters. Boston Scientific had appealed a 1997 jury decision, which found that its Maxforce esophageal dilation balloon catheter infringed on Bard's patent. Boston Scientific notes that the Maxforce has not been sold for several years, and that the $13.3 mil. payment "will have no material financial statement impact"
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT013978

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel